Cardiovascular Diseases Clinical Trial
Official title:
An Evaluation of the Safety and Clinical Utility of Handheld ECG Technology in Psychiatry
Acetylcholinesterase inhibitors and antipsychotics are drugs commonly prescribed in
psychiatry, the former for dementia and the latter for acute and chronic psychotic illness.
Both can cause cardiac arrhythmia therefore 12 lead ECG's are recommended before prescribing.
The test is often difficult to obtain however, leading to either patients being
inconvenienced or drugs prescribed without the test. There are two parts of this study, but
both examine the utility of single lead ecg monitoring, one in the memory clinic and the
other in inpatient psychiatry wards. The aim to to evaluate the safety and efficacy of the
handheld ecg versus the 12 lead and 6 lead ecg, and whether the handheld ecg can be used to
screen for ecg abnormalities that would generally lead to a caution or contra-indication for
acetylcholinesterase inhibitors and anti-psychotic medication.
Patients will either be recruited from the outpatient memory clinic or in patient psychiatry
wards. Following informed consent baseline demographic data will be collected, and patients
will undergo a 12 lead and 6 lead ECG as well as a rhythm strip using the handheld device.
Data from this point will be annonymised for future analysis. The psychiatrists ECG report
will also be recorded, and a subset of patients will undergo an echocardiogram (to see what
proportion of patients with psychiatric disorders have structural heart disease.)
Status | Recruiting |
Enrollment | 1500 |
Est. completion date | August 31, 2021 |
Est. primary completion date | August 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Any patient attending the memory clinic Any patient admitted to the acute psychiatric ward requiring antipsychotic medication Exclusion Criteria: Patients who lack capacity and do not have a personal consultee to provide assent |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Leeds Partnership NHS Foundation Trust | Leeds | West Yorkshire |
Lead Sponsor | Collaborator |
---|---|
The Leeds Teaching Hospitals NHS Trust | Leeds and York Partnership NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ECG monitoring | 12 lead, 6 lead and handheld ECG device monitoring will be undertaken. | 45 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|